CDXS.US Codexis Inc

Healthcare Life Sciences Tools & Services USA Stocks
1.16 USD
Close of Nov 14, 2026
0.9000 2.98
Market cap
USD 127M
P/E
-
P/B
3.18x
ROE
-75.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CDXS.US undervalued?

Graham number

The Graham number of Codexis Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Codexis Inc fundamental analysis

No fundamental analysis for Codexis Inc yet.

Codexis Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Codexis Inc

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic rou…

Full company profile